Skip to content

Savara SVRA Total debt

Total debt at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$258.55M-3.8%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$1.15M-98.1%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$269.43M-40.3%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$40.5M-15.9%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$305.29M-3.5%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$31.26M+3.7%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+236%
Enterprise value$1.19B+224%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Calculated from Savara’s reported figures.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's total debt?
Savara (SVRA) reported total debt of $30.07M in Q1 2026.
How has Savara's total debt changed year-over-year?
Savara's total debt increased by 1.8% year-over-year, from $29.52M to $30.07M.
What is the long-term trend for Savara's total debt?
Over 5 years (2020 to 2025), Savara's total debt has grown at a 3.4% compound annual growth rate (CAGR), from $25.36M to $29.99M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.